DERMAPHARM HLDG INH O.N.

Premiumpartner

Firmenbeschreibung

Dermapharm ist ein Hersteller von patentfreien Markenarzneimitteln für ausgewählte Märkte in Deutschland. Die 1991 gegründete Gesellschaft hat ihren Sitz in Grünwald bei München und ihren Hauptproduktionsstandort in Brehna bei Leipzig. Das integrierte Geschäftsmodell der Gesellschaft umfasst die hausinterne Entwicklung, eigene Produktion sowie den Vertrieb von Arzneimitteln und anderen Gesundheitsprodukten für ausgewählte Märkte durch einen pharmazeutisch geschulten Außendienst. Dermapharm verfügt über rund 1.300 Arzneimittelzulassungen für rund 400 pharmazeutische Wirkstoffe, die sich in einem breiten Produktsortiment widerspiegeln. Zu den Kernmärkten der Gesellschaft gehören derzeit neben Deutschland auch Österreich und die Schweiz. Die Gesellschaft plant, ihre internationale Präsenz weiter auszubauen. Das Geschäftsmodell von Dermapharm umfasst überdies ein Parallelimportgeschäft, das unter der Marke 'axicorp' betrieben wird. Im Segment Pflanzliche Extrakte verfügt Dermapharm über die spanische Euromed S.A. zudem über Zugang zum Wachstumsmarkt für pflanzliche Arzneimittel.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: Themis Beteiligungs-AG (73.4%),Mawer Investment Management Ltd. (3%),Grandeur Peak Global Advisors, LLC (1.55%),Norges Bank Investment Management (1.31%),The Vanguard Group, Inc. (1.22%),Janus Henderson Group plc (0.99%),Amundi Asset Management SAS (0.73%)
sharesOutstanding: 53840000.0000
ceo: Dr. Hans-Georg Feldmeier
board: Christof Dreibholz, Dr. Andreas Eberhorn
supervisoryBoard: Wilhelm Beier, Dr. Erwin Kern, Lothar Lanz
countryID: 2
faceValueCurrencyID: 1
faceValueCurrency: EUR
sectorName: Pharmazeutische Industrie
industryName: Gesundheitswesen
subsectorName: Pharmazeutische Industrie
country: Deutschland
countryName: Deutschland

Kontakt

name: Britta Hamberger
phone: +49-89-64186-233
fax: +49-89-64186-165
email: ir@dermapharm.com
irWebSite: https://ir.dermapharm.de/de/

Adresse

street: Lil-Dagover-Ring 7
city: D-82031 Grünwald
phone: +49-89-64186-0
fax: +49-89-64186-130
webSite: ir.dermapharm.de/index.php

Finanzen (kurz)

year: 2022 cash: 151.0000
balanceSheetTotal: 1412.8000 liabilities: 880.4000
totalShareholdersEquity: 531.6000 sales: 1024.8000
investment: 0.7000 incomeBeforeTaxes: 216.3000
netIncome: 132.6000 employees: 2563
currencyID: 1 units: 1000000
currency: EUR
year: 2023 cash: 158.7200
balanceSheetTotal: 2160.6700 liabilities: 1615.5100
totalShareholdersEquity: 539.2000 sales: 1135.3500
investment: 3.2200 incomeBeforeTaxes: 105.9900
netIncome: 58.1100 employees: 3497
currencyID: 1 units: 1000000
currency: EUR
year: 2024 cash: 121.3000
balanceSheetTotal: 2080.0100 liabilities: 1471.7100
totalShareholdersEquity: 604.4200 sales: 1180.7600
investment: 16.9400 incomeBeforeTaxes: 172.0000
netIncome: 113.7800 currencyID: 1
units: 1000000 currency: EUR

Finanzen (kurz)

year: 2022
cash: 151.0000
balanceSheetTotal: 1412.8000
liabilities: 880.4000
totalShareholdersEquity: 531.6000
sales: 1024.8000
investment: 0.7000
incomeBeforeTaxes: 216.3000
netIncome: 132.6000
employees: 2563
currencyID: 1
units: 1000000
currency: EUR
year: 2023
cash: 158.7200
balanceSheetTotal: 2160.6700
liabilities: 1615.5100
totalShareholdersEquity: 539.2000
sales: 1135.3500
investment: 3.2200
incomeBeforeTaxes: 105.9900
netIncome: 58.1100
employees: 3497
currencyID: 1
units: 1000000
currency: EUR
year: 2024
cash: 121.3000
balanceSheetTotal: 2080.0100
liabilities: 1471.7100
totalShareholdersEquity: 604.4200
sales: 1180.7600
investment: 16.9400
incomeBeforeTaxes: 172.0000
netIncome: 113.7800
currencyID: 1
units: 1000000
currency: EUR

Finanzen (ausführlich)

year: 2023 units: 1000000
balanceSheetTotal: 2160.6700 cash: 158.7200
currentAssets: 630.4900 fixedAssets: 1530.1700
liabilities: 394.4800 nonCurrentLiabilities: 1221.1300
totalLiabilitiesEquity: 2160.6700 provisions: 256.9000
totalShareholdersEquity: 539.2000 employees: 3497
property: 330.7700 intangibleAssets: 544.8600
longTermInvestments: 23.6000 inventories: 320.7500
accountsReceivable: 90.9300 accountsPayable: 86.6400
liabilitiesTotal: 1615.5100 longTermDebt: 963.9500
shortTermDebt: 116.4300 minorityInterests: 5.8400
sales: 1135.3500 depreciation: 104.5800
netIncome: 58.1100 operatingResult: 182.8900
incomeInterest: -69.7400 incomeTaxes: 45.4600
minorityInterestsProfit: 1.8300 revenuePerEmployee: 324663.9977
cashFlow: 219.4200 cashFlowInvesting: -415.4300
cashFlowFinancing: 204.5300 accountingStandard: IFRS
equityRatio: 24.9552 debtEquityRatio: 300.7177
liquidityI: 40.2352 liquidityII: 63.2858
netMargin: 5.1182 cashFlowMargin: 19.3262
ebitMargin: 16.1087 ebitdaMargin: 0.0000
preTaxROE: 19.6569 preTaxROA: 4.9054
roe: 10.7771 roa: 2.6894
netIncomeGrowth: -56.1765 revenuesGrowth: 10.7875
taxExpenseRate: 42.8908 equityTurnover: 2.1056
epsBasic: 1.1600 epsBasicGrowth: -53.4137
priceEarningsRatioCompany: 36.5172 priceCashFlowRatio: 10.3940
dividendYield: 2.0774 bookValuePerShare: 10.0149
marketCap: 2280662400.0000 earningsYield: 2.7384
pegRatio: -0.6837 cashFlowPerShare: 4.0754
netAssetsPerShare: 10.1233 priceBookValueRatio: 4.2297
dividendsPerShare: 0.8800 priceEarningsRatio: 39.2473
netEarningsPerShare: 1.0793 currency: EUR
year: 2024 units: 1000000
balanceSheetTotal: 2080.0100 cash: 121.3000
currentAssets: 593.4900 fixedAssets: 1486.5200
liabilities: 326.9100 nonCurrentLiabilities: 1144.8000
totalLiabilitiesEquity: 2080.0100 provisions: 143.0000
totalShareholdersEquity: 604.4200 property: 315.0200
longTermInvestments: 20.6600 inventories: 343.3800
accountsReceivable: 100.9000 accountsPayable: 94.7800
liabilitiesTotal: 1471.7100 longTermDebt: 889.6700
shortTermDebt: 89.9300 minorityInterests: 3.8700
sales: 1180.7600 depreciation: 90.4900
netIncome: 113.7800 operatingResult: 216.9300
incomeInterest: -46.4500 incomeTaxes: 60.2600
minorityInterestsProfit: -2.0500 cashFlow: 201.3700
cashFlowInvesting: -29.6100 cashFlowFinancing: -209.1600
accountingStandard: IFRS equityRatio: 29.0585
debtEquityRatio: 244.1332 liquidityI: 37.1050
liquidityII: 67.9698 netMargin: 9.6362
cashFlowMargin: 17.0543 ebitMargin: 18.3721
ebitdaMargin: 0.0000 preTaxROE: 28.4570
preTaxROA: 8.2692 roe: 18.8247
roa: 5.4702 netIncomeGrowth: 95.8011
revenuesGrowth: 3.9996 taxExpenseRate: 35.0349
equityTurnover: 1.9535 epsBasic: 2.1100
epsBasicGrowth: 81.8966 priceEarningsRatioCompany: 18.4360
priceCashFlowRatio: 10.4006 dividendYield: 2.3136
bookValuePerShare: 11.2262 marketCap: 2094376000.0000
earningsYield: 5.4242 pegRatio: 0.2251
cashFlowPerShare: 3.7402 netAssetsPerShare: 11.2981
priceBookValueRatio: 3.4651 dividendsPerShare: 0.9000
priceEarningsRatio: 18.4072 netEarningsPerShare: 2.1133
currency: EUR
year: 2025 priceEarningsRatioCompany: 18.2227
priceCashFlowRatio: 10.2803 dividendYield: 2.3407
bookValuePerShare: 11.2262 marketCap: 2070148000.0000
earningsYield: 5.4876 pegRatio: 0.2225
cashFlowPerShare: 3.7402 netAssetsPerShare: 11.2262
priceBookValueRatio: 3.4250 priceEarningsRatio: 18.1943
netEarningsPerShare: 2.1133 currency: EUR

Finanzen (ausführlich)

year: 2023
units: 1000000
balanceSheetTotal: 2160.6700
cash: 158.7200
currentAssets: 630.4900
fixedAssets: 1530.1700
liabilities: 394.4800
nonCurrentLiabilities: 1221.1300
totalLiabilitiesEquity: 2160.6700
provisions: 256.9000
totalShareholdersEquity: 539.2000
employees: 3497
property: 330.7700
intangibleAssets: 544.8600
longTermInvestments: 23.6000
inventories: 320.7500
accountsReceivable: 90.9300
accountsPayable: 86.6400
liabilitiesTotal: 1615.5100
longTermDebt: 963.9500
shortTermDebt: 116.4300
minorityInterests: 5.8400
sales: 1135.3500
depreciation: 104.5800
netIncome: 58.1100
operatingResult: 182.8900
incomeInterest: -69.7400
incomeTaxes: 45.4600
minorityInterestsProfit: 1.8300
revenuePerEmployee: 324663.9977
cashFlow: 219.4200
cashFlowInvesting: -415.4300
cashFlowFinancing: 204.5300
accountingStandard: IFRS
equityRatio: 24.9552
debtEquityRatio: 300.7177
liquidityI: 40.2352
liquidityII: 63.2858
netMargin: 5.1182
cashFlowMargin: 19.3262
ebitMargin: 16.1087
ebitdaMargin: 0.0000
preTaxROE: 19.6569
preTaxROA: 4.9054
roe: 10.7771
roa: 2.6894
netIncomeGrowth: -56.1765
revenuesGrowth: 10.7875
taxExpenseRate: 42.8908
equityTurnover: 2.1056
epsBasic: 1.1600
epsBasicGrowth: -53.4137
priceEarningsRatioCompany: 36.5172
priceCashFlowRatio: 10.3940
dividendYield: 2.0774
bookValuePerShare: 10.0149
marketCap: 2280662400.0000
earningsYield: 2.7384
pegRatio: -0.6837
cashFlowPerShare: 4.0754
netAssetsPerShare: 10.1233
priceBookValueRatio: 4.2297
dividendsPerShare: 0.8800
priceEarningsRatio: 39.2473
netEarningsPerShare: 1.0793
currency: EUR
year: 2024
units: 1000000
balanceSheetTotal: 2080.0100
cash: 121.3000
currentAssets: 593.4900
fixedAssets: 1486.5200
liabilities: 326.9100
nonCurrentLiabilities: 1144.8000
totalLiabilitiesEquity: 2080.0100
provisions: 143.0000
totalShareholdersEquity: 604.4200
property: 315.0200
longTermInvestments: 20.6600
inventories: 343.3800
accountsReceivable: 100.9000
accountsPayable: 94.7800
liabilitiesTotal: 1471.7100
longTermDebt: 889.6700
shortTermDebt: 89.9300
minorityInterests: 3.8700
sales: 1180.7600
depreciation: 90.4900
netIncome: 113.7800
operatingResult: 216.9300
incomeInterest: -46.4500
incomeTaxes: 60.2600
minorityInterestsProfit: -2.0500
cashFlow: 201.3700
cashFlowInvesting: -29.6100
cashFlowFinancing: -209.1600
accountingStandard: IFRS
equityRatio: 29.0585
debtEquityRatio: 244.1332
liquidityI: 37.1050
liquidityII: 67.9698
netMargin: 9.6362
cashFlowMargin: 17.0543
ebitMargin: 18.3721
ebitdaMargin: 0.0000
preTaxROE: 28.4570
preTaxROA: 8.2692
roe: 18.8247
roa: 5.4702
netIncomeGrowth: 95.8011
revenuesGrowth: 3.9996
taxExpenseRate: 35.0349
equityTurnover: 1.9535
epsBasic: 2.1100
epsBasicGrowth: 81.8966
priceEarningsRatioCompany: 18.4360
priceCashFlowRatio: 10.4006
dividendYield: 2.3136
bookValuePerShare: 11.2262
marketCap: 2094376000.0000
earningsYield: 5.4242
pegRatio: 0.2251
cashFlowPerShare: 3.7402
netAssetsPerShare: 11.2981
priceBookValueRatio: 3.4651
dividendsPerShare: 0.9000
priceEarningsRatio: 18.4072
netEarningsPerShare: 2.1133
currency: EUR
year: 2025
priceEarningsRatioCompany: 18.2227
priceCashFlowRatio: 10.2803
dividendYield: 2.3407
bookValuePerShare: 11.2262
marketCap: 2070148000.0000
earningsYield: 5.4876
pegRatio: 0.2225
cashFlowPerShare: 3.7402
netAssetsPerShare: 11.2262
priceBookValueRatio: 3.4250
priceEarningsRatio: 18.1943
netEarningsPerShare: 2.1133
currency: EUR